Literature DB >> 23279758

Performance evaluation of the Abbott CELL-DYN Emerald for use as a bench-top analyzer in a research setting.

T-L Khoo1, N Xiros, F Guan, D Orellana, J Holst, D E Joshua, J E J Rasko.   

Abstract

INTRODUCTION: The CELL-DYN Emerald is a compact bench-top hematology analyzer that can be used for a three-part white cell differential analysis. To determine its utility for analysis of human and mouse samples, we evaluated this machine against the larger CELL-DYN Sapphire and Sysmex XT2000iV hematology analyzers.
METHODS: 120 human (normal and abnormal) and 30 mouse (normal and abnormal) samples were analyzed on both the CELL-DYN Emerald and CELL-DYN Sapphire or Sysmex XT2000iV analyzers. For mouse samples, the CELL-DYN Emerald analyzer required manual recalibration based on the histogram populations.
RESULTS: Analysis of the CELL-DYN Emerald showed excellent precision, within accepted ranges (white cell count CV% = 2.09%; hemoglobin CV% = 1.68%; platelets CV% = 4.13%). Linearity was excellent (R² ≥ 0.99), carryover was minimal (<1%), and overall interinstrument agreement was acceptable for both human and mouse samples. Comparison between the CELL-DYN Emerald and Sapphire analyzers for human samples or Sysmex XT2000iV analyzer for mouse samples showed excellent correlation for all parameters.
CONCLUSION: The CELL-DYN Emerald was generally comparable to the larger reference analyzer for both human and mouse samples. It would be suitable for use in satellite research laboratories or as a backup system in larger laboratories.
© 2012 John Wiley & Sons Ltd.

Entities:  

Keywords:  Analytical performance; CELL-DYN Emerald; automated hematology analyzer; human full blood count; mouse full blood count

Mesh:

Year:  2012        PMID: 23279758     DOI: 10.1111/ijlh.12040

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  2 in total

1.  Efficient role of IgH 3' regulatory region deficient B-cells in the development of oil granulomas.

Authors:  Nour Ghazzaui; Alexis Saintamand; Hussein Issaoui; Faten Saad; Yves Denizot
Journal:  Oncotarget       Date:  2016-06-21

2.  Clinical and hematological characteristics of 300 COVID-19 patients in Erbil, Kurdistan Region, Iraq.

Authors:  Rundk Ahmad Hwaiz; Sahar Mohammed Zaki Abdullah; Salah Tofik Jalal Balaky; Katan Sabir Ali; Mohammed Yousif Merza; Shakhawan Assad Khailani; Nazar Pauls Shabila
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.